Table 2 Evaluation of vascular risk factors
Laboratory tests | CADASIL patients (n = 24) | CADASIL-like patients (n = 92) | P value |
|---|---|---|---|
ALT, u/l | 26.67 ± 4.96 | 27.16 ± 4.66 | 0.964 |
AST, u/l | 25.70 ± 4.90 | 25.80 ± 2.36 | 0.986 |
Chol, mmol/l | 3.48 ± 0.34 | 3.80 ± 0.13 | 0.330 |
TG, mmol/l | 1.49 ± 0.094 | 1.50 ± 0.309 | 0.958 |
HDL, mmol/l | 1.03 ± 0.094 | 0.99 ± 0.048 | 0.763 |
LDL, mmol/l | 1.91 ± 0.253 | 2.40 ± 0.120 | 0.101 |
Cr, umol/l | 85.38 ± 6.904 | 86.16 ± 6.577 | 0.959 |
homocysteine, umol/l | 14.43 ± 1.947 | 18.8 ± 1.785 | 0.043 |
NT-proBNP, pg/ml | 252.50 ± 185.114 | 406.79 ± 204.656 | 0.706 |
cTnI, ng/ml | 0.02 ± 0.016 | 0.28 ± 0.275 | 0.623 |
FBG, mmol/l | 5.85 ± 0.541 | 6.43 ± 0.467 | 0.640 |